CIM INVESTMENT MANAGEMENT INC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 242 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
CIM INVESTMENT MANAGEMENT INC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$246,000
+7.9%
9,5890.0%0.11%
+14.7%
Q2 2022$228,000
+5.6%
9,5890.0%0.10%
+30.1%
Q1 2022$216,000
+1.9%
9,589
-10.5%
0.07%
+15.9%
Q4 2021$212,000
+0.5%
10,7130.0%0.06%
-4.5%
Q3 2021$211,000
-10.6%
10,7130.0%0.07%
-9.6%
Q2 2021$236,000
-7.5%
10,7130.0%0.07%
-8.8%
Q1 2021$255,000
-14.1%
10,713
-5.7%
0.08%
-16.7%
Q4 2020$297,000
+50.0%
11,3560.0%0.10%
+28.0%
Q3 2020$198,000
-47.5%
11,356
-49.3%
0.08%
-50.7%
Q2 2020$377,000
+13.9%
22,390
-19.5%
0.15%
-6.2%
Q1 2020$331,000
+46.5%
27,802
+48.6%
0.16%
+82.0%
Q4 2019$226,000
-52.0%
18,711
-43.9%
0.09%
-49.4%
Q3 2019$471,000
+26.6%
33,3310.0%0.18%
+29.4%
Q2 2019$372,000
-6.8%
33,331
-2.0%
0.14%
-11.1%
Q1 2019$399,000
-12.9%
34,026
-0.8%
0.15%
-23.1%
Q4 2018$458,000
+95.7%
34,315
+105.3%
0.20%
+136.9%
Q3 2018$234,000
-11.0%
16,7130.0%0.08%
-7.7%
Q2 2018$263,00016,7130.09%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,825,262$138,6217.54%
Novo Holdings A/S 3,377,768$68,602,4684.28%
Parallel Advisors, LLC 3,724,664$75,647,9263.28%
TANAKA CAPITAL MANAGEMENT INC 35,539$7222.29%
Quantedge Capital Pte Ltd 251,312$5,104,1471.71%
S&T BANK/PA 346,306$7,0331.30%
Freshford Capital Management, LLC 249,000$5,057,1901.09%
Birchview Capital, LP 50,000$1,0160.72%
FAS Wealth Partners, Inc. 306,276$6,220,4660.70%
Bridge City Capital, LLC 60,824$1,2350.63%
View complete list of CORCEPT THERAPEUTICS INC shareholders